Journal article icon

Journal article

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.

Abstract:

BACKGROUND: Before 2001, the incidence of invasive meningococcal disease (IMD) in Canada was 1.0 per 100 000 per year, with 40% of cases caused by serogroup C organisms. During 2001-2005 all provinces introduced the meningococcal serogroup C conjugate vaccine (MCCV) into their routine infant immunization schedule. METHODS: Active, prospective, population-based surveillance of IMD in children and adults was conducted by the Canadian Immunization Monitoring Program, ACTive (IMPACT) during 2002-...

Expand abstract

Actions


Access Document


Publisher copy:
10.1093/cid/ciu597

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Paediatrics
Scheifele, DW More by this author
Halperin, SA More by this author
Le Saux, N More by this author
Expand authors...
Publisher:
Oxford University Press
Journal:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume:
59
Issue:
9
Pages:
1208-1215
Publication date:
2014-11-05
DOI:
EISSN:
1537-6591
ISSN:
1058-4838
URN:
uuid:bbde6c60-de7c-4760-b876-061dc381ed88
Source identifiers:
479249
Local pid:
pubs:479249

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP